Literature DB >> 30690399

Hierarchical biomimetic BiVO4 for the treatment of pharmaceutical wastewater in visible-light photocatalytic ozonation.

Xuelian Liu1, Zhuang Guo2, Linbi Zhou1, Jin Yang2, Hongbin Cao1, Mei Xiong2, Yongbing Xie3, Guangru Jia4.   

Abstract

Photocatalytic ozonation is an attractive advanced oxidation process for wastewater treatment, but highly active catalysts with strong response to visible light are urgently needed to push forward its practical application. In this study, a hierarchical biomimetic monoclinic bismuth vanadate (BiVO4) with leaves morphology was synthesized by a hydrothermal method, and employed as catalyst for oxalic acid and penicillin degradation in photocatalytic ozonation. The results show that the organics degradation was more efficient using leaves shaped BiVO4 as catalyst than the bulk shaped one in photocatalytic ozonation and the synergy index is ranged from 2.8 to 3.3, indicating a superior positive synergistic effect between photocatalysis and ozonation. The higher activity of the leaves shaped BiVO4 was probably attributed to the distinctive biomimetic morphology and preferable band structure with more negative CB potential. Mechanism studies suggested that the main reactive species were h+ and OH for the degradation of persistent oxalic acid in photocatalytic ozonation. In addition, the effect of ozone concentration and inorganic ions and reusability of the material were also intensively investigated.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BiVO(4); Biomimetic morphology; Photocatalytic ozonation; Photogenerated hole; Synergies

Mesh:

Substances:

Year:  2019        PMID: 30690399     DOI: 10.1016/j.chemosphere.2019.01.084

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  1 in total

1.  Photocatalytic degradation of ibuprofen using titanium oxide: insights into the mechanism and preferential attack of radicals.

Authors:  Maicon Oliveira Miranda; Wesley Eulálio Cabral Cavalcanti; Felipe Fernandes Barbosa; José Antonio de Sousa; Francisco Ivan da Silva; Sibele B C Pergher; Tiago Pinheiro Braga
Journal:  RSC Adv       Date:  2021-08-16       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.